News
The LymphoSign Kit, plays a crucial role in establishing accurate diagnoses and treatment plans for non-Hodgkin’s lymphoma. Leveraging RNA expression levels from over 130 relevant gene markers, this state-of-the-art method provides valuable insights into disease progression. Its simple, fast protocol and suitability for challenging samples make it a powerful tool in non-Hodgkin’s lymphoma research and patient care .
The SarcomaFusion test detects fusion transcripts in sarcomas. These transcripts, associated with specific subtypes and targeted treatments, are crucial for patient care. Using patented ligation-dependent PCR technology, the test simplifies diagnostics and enhances our understanding of sarcoma biology. Its rapid protocol and robustness make it a valuable tool in oncology.